Jane Street Group, LLC Macrogenics Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 522,197 shares of MGNX stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

522,197

Previous 487,201 7.18%

Holding current value

$1.71 Million

Previous $2.07 Million 17.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $104,988 - $194,227	34,996 Added 7.18%	522,197 $1.72 Million
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $359,724 - $2.01 Million	108,678 Added 28.71%	487,201 $2.07 Million
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $2.99 Million - $6.56 Million	305,684 Added 419.67%	378,523 $5.57 Million
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $262,174 - $591,647	58,521 Added 408.72%	72,839 $700,000
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $64,144 - $88,628	14,318 New	14,318 $66,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $54,037 - $81,167	11,211 Added 36.19%	42,189 $302,000
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $103,466 - $216,226	30,978 New	30,978 $207,000
Q2 2022 Aug 16, 2022	BUY	$2.25 - $9.99 $155,241 - $689,270	68,996 New	68,996 $203,000
Q1 2022 May 17, 2022	SELL	$8.12 - $16.9 $143,683 - $299,045	-17,695 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$15.91 - $21.88 $56,289 - $77,411	3,538 Added 24.99%	17,695 $284,000
Q3 2021 Nov 16, 2021	BUY	$19.74 - $28.7 $123,019 - $178,858	6,232 Added 78.64%	14,157 $296,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $434,469 - $755,498	-21,204 Reduced 72.79%	7,925 $212,000
Q1 2021 May 18, 2021	BUY	$18.99 - $33.2 $269,904 - $471,871	14,213 Added 95.29%	29,129 $928,000
Q4 2020 Feb 17, 2021	SELL	$19.41 - $26.0 $1,378 - $1,846	-71 Reduced 0.47%	14,916 $341,000
Q3 2020 Nov 17, 2020	BUY	$24.69 - $31.6 $54,515 - $69,772	2,208 Added 17.28%	14,987 $378,000
Q2 2020 Aug 17, 2020	BUY	$5.2 - $29.12 $66,450 - $372,124	12,779 New	12,779 $357,000
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $58,023 - $164,175	-13,557 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $27,077 - $41,791	3,406 Added 33.55%	13,557 $148,000
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $126,278 - $177,439	10,151 New	10,151 $130,000
Q2 2019 Aug 15, 2019	SELL	$14.51 - $19.71 $330,639 - $449,131	-22,787 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$11.11 - $25.6 $253,163 - $583,347	22,787 New	22,787 $410,000
Q2 2018 Aug 15, 2018	SELL	$19.78 - $24.67 $319,585 - $398,593	-16,157 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $305,205 - $524,456	16,157 New	16,157 $407,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $202M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Macrogenics Inc Transaction History